Rheumatoid Arthritis 
The MD Magazine Rheumatoid Arthritis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Rheumatoid Arthritis Treatment Wins FDA Approval
Sarilumab would be able to treat adult patients with moderately-to-severely active rheumatoid arthritis who cannot tolerate one or more disease modifying antirheumatic drugs like methotrexate.
This is the first FDA-approved therapy specific to this form of vasculitis.
At AAPA 2017, Benjamin Smith, PA-C, DFAAPA, Florida State University College of Medicine, discussed the tremendous advances in both treating and diagnosing rheumatoid arthritis. About 15 years ago, the CCP lab tests came about, which certainly help with specificity for diagnosing rheumatoid arthritis (RA).
Arthritis may soon be combated by rewired stem cells.
FDA to consider Xeljanz, the sole JAK inhibitor available in US, for new indication.
Factors include elevated carbohydrate antigen 125 and lactate dehydrogenase.
Infliximab-abda approved for range of gastroenterological and rheumatoid conditions.
At one year, nearly as many on monotherapy were in remission as on combo therapy.
Company hopes former RA candidate will be approved for rare blood condition.

Most Popular


$vacMongoViewPlus$ $vAR$